SCI-Group

About

SCI-Group AS is a Norwegian deep technology company dedicated to transforming the global cryopreservation industry. Founded in 2005, the company has developed a patented cryopreservation technology.

Technology

CryoEmbla

CryoEmbla is SCI-Group's patented core technology enabling:

• Cryopreservation of living cells entirely without cytotoxic chemical cryoprotectants
• Significantly reduced use of cryoprotectants compared to conventional methods
• Safe, rapid, and efficient freezing of living cells
• Simplified handling and workflow
• Cryopreservation without DMSO or with strongly reduced DMSO

Conventional cryopreservation relies heavily on DMSO (dimethyl sulfoxide), which is cytotoxic and requires careful handling. CryoEmbla addresses this fundamental limitation.

Applications

• Cell therapy manufacturing
• Biobanking
• Advanced life sciences research
• Broader clinical and industrial use of living cells

Strategy

SCI-Group works closely with leading research institutions, industry partners, and investors to accelerate adoption of next-generation cryopreservation.

Vision

To set a new global standard for safe, efficient, and reproducible cryopreservation — unlocking value for medicine, science, and society.